Zura Bio (ZURA) Current Assets (2021 - 2026)

Zura Bio's Current Assets history runs 6 years deep, the most recent figure standing at $227.0 million for Q1 2026.

• On a quarterly basis, Current Assets rose 32.22% year-over-year to $227.0 million in Q1 2026; TTM through Mar 2026 was $227.0 million, a 32.22% increase from a year earlier, with the FY2025 full-year figure at $112.3 million, down 37.17% from the prior year.
• Current Assets improved to $227.0 million in Q1 2026 per ZURA's latest filing, from $112.3 million in the prior quarter.
• Across five years, Current Assets topped out at $227.0 million in Q1 2026 and bottomed at $196655.0 in Q3 2022.
• The 5-year median for Current Assets is $112.3 million (2025), against an average of $107.3 million.
• Across the five-year window, Current Assets soared 53085.53% in 2023 and sank 37.17% in 2025, its largest moves.
• Year by year, Current Assets stood at $1.8 million in 2022, then surged by 5578.1% to $100.8 million in 2023, then jumped by 77.25% to $178.7 million in 2024, then sank by 37.17% to $112.3 million in 2025, then jumped by 102.12% to $227.0 million in 2026.
• Per Business Quant, the three latest ZURA Current Assets figures stand at $227.0 million (Q1 2026), $112.3 million (Q4 2025), and $142.3 million (Q3 2025).